K. Suzuki

Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.

K. Takeuchi, H. Yamamoto, H. Mizoguchi, 1998, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.

K. Takeuchi, S. Kato, H. Araki, 2001, The Journal of pharmacology and experimental therapeutics.

Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.

K. Wada, S. Futagami, A. Tatsuguchi, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells

K. Wada, S. Futagami, A. Tatsuguchi, 2003, Gut.

Gastrointestinal sparing anti-inflammatory drugs--effects on ulcerogenic and healing responses.

K. Takeuchi, H. Mizoguchi, A. Tanaka, 2001, Current pharmaceutical design.

The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach

K. Takeuchi, H. Araki, Y. Sugawa, 2000, Alimentary pharmacology & therapeutics.

Preventive therapy for non‐steroidal anti‐inflammatory drug‐induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled‐study of the preventive effects of lansoprazole or famotidine

K. Wada, S. Futagami, C. Sakamoto, 2005, Alimentary pharmacology & therapeutics.

Helicobacter pylori infection induces accumulation of Vδ1 T cells via CCR2 upregulation

K. Wada, S. Futagami, T. Shindo, 2006 .

Chemopreventive effect of celecoxib in gastric cancer

S. Futagami, T. Shindo, C. Sakamoto, 2007, Inflammopharmacology.